23 results on '"Schlamm, Haran T"'
Search Results
2. Fosmanogepix Therapy of Disseminated Fusarium Infection
3. 147. Clinical Safety and Efficacy of Novel Antifungal, Fosmanogepix, in the Treatment of Candidemia: Results from a Phase 2 Proof of Concept Trial
4. 1157. Clinical Safety, Efficacy, and Pharmacokinetics of Fosmanogepix, a Novel First-in-class Antifungal, in Patients with Renal Insufficiency: Subset Analysis from a Phase 2 Candidemia Trial
5. Combination Therapy for Invasive Aspergillosis: Controversies and Conclusions
6. Combination Antifungal Therapy for Invasive Aspergillosis
7. Application of the 2008 Definitions for Invasive Fungal Diseases to the Trial Comparing Voriconazole Versus Amphotericin B for Therapy of Invasive Aspergillosis: A Collaborative Study of the Mycoses Study Group (MSG 05) and the European Organization for Research and Treatment of Cancer Infectious Diseases Group
8. Voriconazole or Amphotericin B as Primary Therapy Yields Distinct Early Serum Galactomannan Trends Related to Outcomes in Invasive Aspergillosis
9. An open‐label study of anidulafungin for the treatment of candidaemia/invasive candidiasis in Latin America
10. Aspergillosis in Intensive Care Unit (ICU) patients: epidemiology and economic outcomes
11. Early Serum Galactomannan Trend as a Predictor of Outcome of Invasive Aspergillosis
12. Tissue Distribution of Anidulafungin in Neonatal Rats
13. Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome
14. Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: Support for the 2009 IDSA treatment guidelines for candidiasis
15. Early Proinflammatory Cytokines and C‐Reactive Protein Trends as Predictors of Outcome in Invasive Aspergillosis
16. Review of the Basic and Clinical Pharmacology of Sulfobutylether-β-Cydodextrin (SBECD)
17. Changes in causes of death over time after treatment for invasive aspergillosis
18. Voriconazole as Therapy for Systemic Penicillium marneffei Infections in AIDS Patients
19. Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections
20. Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
21. Nutritional and metabolic assessment of the hospitalized patient
22. Clinical Effectiveness of a Pancreatic Enzyme Supplement
23. Haemophilus influenzae pneumonia in young adults with AIDS, ARC, or risk of AIDS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.